Pyxis Oncology, Inc. (NASDAQ:PYXS) IPO
IPO
Priced at US$16.00 a share on Oct 7, 2021.
- Price
- US$16.00 a share
- Shares offered
- 10,500,000 shares of common stock
- Offering size
- US$168 million
- Underwriters' option
- Up to 1,575,000 more shares
- Underwriters
- BofA Securities, Jefferies, Credit Suisse, William Blair, LifeSci Capital · In the order on the cover
- Shares delivered
- On or about Oct 13, 2021
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jun 21, 2021 |
| Filed publicly | Sep 17, 2021 |
| Amended 3 times | Newest Oct 7, 2021 |
| Shares registered with an exchange | Oct 5, 2021 |
| Declared effective by the SEC | Oct 7, 2021 |
| Final prospectus, with the price | Oct 8, 2021 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Oct 8, 2021 |
| EFFECT · Notice that a registration is effective | Oct 7, 2021 |
| S-1MEF · Registration of more shares for the same offering | Oct 7, 2021 |
| S-1/A · Registration statement, amended | Oct 7, 2021 |
| CERT · Exchange's certificate of listing | Oct 6, 2021 |
| 8-A12B · Registration of shares for listing on an exchange | Oct 5, 2021 |
| CORRESP · Letter to the SEC | Oct 5, 2021 |
| CORRESP · Letter to the SEC | Oct 5, 2021 |
| S-1/A · Registration statement, amended | Oct 4, 2021 |
| S-1/A · Registration statement, amended | Oct 1, 2021 |
| CORRESP · Letter to the SEC | Sep 28, 2021 |
| S-1 · Registration statement | Sep 17, 2021 |
| DRS/A · Draft registration statement, amended | Sep 10, 2021 |
| DRSLTR · Letter to the SEC with a draft | Sep 9, 2021 |
| UPLOAD · Letter from the SEC | Aug 18, 2021 |
| DRSLTR · Letter to the SEC with a draft | Aug 4, 2021 |
| DRS/A · Draft registration statement, amended | Aug 4, 2021 |
| UPLOAD · Letter from the SEC | Jul 16, 2021 |
| DRS · Draft registration statement | Jun 21, 2021 |
From the cover of the final prospectus (424B4) filed Oct 8, 2021